Literature DB >> 16352542

Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.

Ihab Younis1, Kathleen Boris-Lawrie, Patrick L Green.   

Abstract

Human T-cell leukemia virus (HTLV) infection is a chronic, lifelong infection that is associated with the development of leukemia and neurological disease after a long latency period, and the mechanism by which the virus is able to evade host immune surveillance is elusive. Besides the structural and enzymatic proteins, HTLV encodes regulatory (Tax and Rex) and accessory (open reading frame I [ORF I] and ORF II) proteins. Tax activates viral and cellular transcription and promotes T-cell growth and malignant transformation. Rex acts posttranscriptionally to facilitate cytoplasmic expression of incompletely spliced viral mRNAs. Recently, we reported that the accessory gene products of HTLV-1 and HTLV-2 ORF II (p30II and p28II, respectively) are able to restrict viral replication. These proteins act as negative regulators of both Tax and Rex by binding to and retaining their mRNA in the nucleus, leading to reduced protein expression and virion production. Here, we show that p28II is recruited to the viral promoter in a Tax-dependent manner. After recruitment to the promoter, p28II or p30II then travels with the transcription elongation machinery until its target mRNA is synthesized. Experiments artificially directing these proteins to the promoter indicate that p28II, unlike HTLV-1 p30II, displays no transcriptional activity. Furthermore, the tethering of p28II directly to tax/rex mRNA resulted in repression of Tax function, which could be attributed to the ability of p28II to block TAP/p15-mediated enhancement of Tax expression. p28II-mediated reduction of viral replication in infected cells may permit survival of the cells by allowing escape from immune recognition, which is consistent with the critical role of HTLV accessory proteins in viral persistence in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16352542      PMCID: PMC1317543          DOI: 10.1128/JVI.80.1.181-191.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  RNA polymerase II and the integration of nuclear events.

Authors:  Y Hirose; J L Manley
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

2.  Splicing is required for rapid and efficient mRNA export in metazoans.

Authors:  M J Luo; R Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

4.  Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells.

Authors:  T M Ross; M Narayan; Z Y Fang; A C Minella; P L Green
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.

Authors:  J T Bartoe; B Albrecht; N D Collins; M D Robek; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.

Authors:  W Zhang; J W Nisbet; B Albrecht; W Ding; F Kashanchi; J T Bartoe; M D Lairmore
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Molecular characterization of genome of a novel human T-cell leukaemia virus.

Authors:  I S Chen; J McLaughlin; J C Gasson; S C Clark; D W Golde
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

9.  Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export.

Authors:  I C Braun; A Herold; M Rode; E Conti; E Izaurralde
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

10.  Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.

Authors:  W Zhang; J W Nisbet; J T Bartoe; W Ding; M D Lairmore
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

View more
  12 in total

1.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Authors:  Min Li; Patrick L Green
Journal:  J Virol Methods       Date:  2007-03-06       Impact factor: 2.014

2.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

3.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

4.  Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.

Authors:  Bindhu Michael; Amrithraj M Nair; Antara Datta; Hajime Hiraragi; Lee Ratner; Michael D Lairmore
Journal:  Virology       Date:  2006-08-04       Impact factor: 3.616

5.  Discovery and characterization of auxiliary proteins encoded by type 3 simian T-cell lymphotropic viruses.

Authors:  Jocelyn Turpin; Chloé Journo; Nga Ling Ko; Flore Sinet; Alexandre Carpentier; Amandine Galioot; Dustin Edwards; Anne-Mieke Vandamme; Louis Gazzolo; Madeleine Duc Dodon; Antoine Gessain; Fatah Kashanchi; Ivan Balansard; Romain Lacoste; Renaud Mahieux
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

6.  Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma.

Authors:  Robert Harrod
Journal:  Leuk Res       Date:  2011-08-24       Impact factor: 3.156

7.  Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.

Authors:  Rami Doueiri; Rajaneesh Anupam; Mamuka Kvaratskhelia; Kari B Green; Michael D Lairmore; Patrick L Green
Journal:  Retrovirology       Date:  2012-08-09       Impact factor: 4.602

Review 8.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

9.  Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo.

Authors:  Brenda Yamamoto; Min Li; Matthew Kesic; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  Retrovirology       Date:  2008-05-12       Impact factor: 4.602

Review 10.  The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle.

Authors:  Rajaneesh Anupam; Rami Doueiri; Patrick L Green
Journal:  Front Microbiol       Date:  2013-09-17       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.